• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种辛糖酮还原酶和两种酰基转移酶参与保罗霉素的生物合成。

Involvement of an octose ketoreductase and two acyltransferases in the biosynthesis of paulomycins.

作者信息

Li Jine, Wang Min, Ding Yong, Tang Yue, Zhang Zhiguo, Chen Yihua

机构信息

State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

University of Chinese Academy of Sciences, Beijing, 110039, China.

出版信息

Sci Rep. 2016 Feb 15;6:21180. doi: 10.1038/srep21180.

DOI:10.1038/srep21180
PMID:26877148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4753412/
Abstract

C-4 hydroxyethyl branched octoses have been observed in polysaccharides of several genera of gram negative bacteria and in various antibiotics produced by gram positive bacteria. The C-4 hydroxyethyl branch was proposed to be converted from C-4 acetyl branch by an uncharacterized ketoreduction step. Paulomycins (PAUs) are glycosylated antibiotics with potent inhibitory activity against gram positive bacteria and are structurally defined by its unique C-4' hydroxyethyl branched paulomycose moiety. A novel aldo-keto-reductase, Pau7 was characterized as the enzyme catalyzing the stereospecific ketoreduction of 7'-keto of PAU E (1) to give the C-4' hydroxyethyl branched paulomycose moiety of PAU F (2). An acyltransferase Pau6 further decorates the C-4' hydroxyethyl branch of paulomycose moiety of 2 by attaching various fatty acyl chains to 7'-OH to generate diverse PAUs. In addition, another acyltransferase Pau24 was proposed to be responsible for the 13-O-acetylation of PAUs.

摘要

在几种革兰氏阴性菌的多糖以及革兰氏阳性菌产生的各种抗生素中,已观察到C-4羟乙基支链辛糖。有人提出,C-4羟乙基支链是通过一个未明确的酮还原步骤从C-4乙酰基支链转化而来的。保洛霉素(PAUs)是一类糖基化抗生素,对革兰氏阳性菌具有强大的抑制活性,其结构特点是具有独特的C-4'羟乙基支链的保洛糖部分。一种新型醛酮还原酶Pau7被鉴定为催化将保洛霉素E(1)的7'-酮立体选择性还原为保洛霉素F(2)的C-4'羟乙基支链保洛糖部分的酶。一种酰基转移酶Pau6通过将各种脂肪酰链连接到7'-OH上,进一步修饰2的保洛糖部分的C-4'羟乙基支链,从而产生多种保洛霉素。此外,另一种酰基转移酶Pau24被认为负责保洛霉素的13-O-乙酰化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/a5d196ba55cc/srep21180-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/9435aef12a86/srep21180-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/71a8641567fd/srep21180-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/50e5dfc0f641/srep21180-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/a5d196ba55cc/srep21180-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/9435aef12a86/srep21180-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/71a8641567fd/srep21180-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/50e5dfc0f641/srep21180-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ca/4753412/a5d196ba55cc/srep21180-f4.jpg

相似文献

1
Involvement of an octose ketoreductase and two acyltransferases in the biosynthesis of paulomycins.一种辛糖酮还原酶和两种酰基转移酶参与保罗霉素的生物合成。
Sci Rep. 2016 Feb 15;6:21180. doi: 10.1038/srep21180.
2
Characterization of a 3-hydroxyanthranilic acid 6-hydroxylase involved in paulomycin biosynthesis.鉴定参与保罗霉素生物合成的 3-羟基邻氨基苯甲酸 6-羟化酶。
Biochem Biophys Res Commun. 2021 Mar 5;543:8-14. doi: 10.1016/j.bbrc.2021.01.042. Epub 2021 Jan 23.
3
Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074.新型白色链霉菌 J1074 产生的生物活性博来霉素衍生物。
Molecules. 2017 Oct 18;22(10):1758. doi: 10.3390/molecules22101758.
4
New insights into paulomycin biosynthesis pathway in Streptomyces albus J1074 and generation of novel derivatives by combinatorial biosynthesis.白色链霉菌J1074中保洛霉素生物合成途径的新见解及通过组合生物合成产生新型衍生物
Microb Cell Fact. 2016 Mar 21;15:56. doi: 10.1186/s12934-016-0452-4.
5
New paulomycins produced by Streptomyces paulus.保罗链霉菌产生的新型保罗霉素。
J Antibiot (Tokyo). 1988 Feb;41(2):157-69. doi: 10.7164/antibiotics.41.157.
6
Chemoenzymatic formation of novel aminocoumarin antibiotics by the enzymes CouN1 and CouN7.通过CouN1和CouN7酶进行新型氨基香豆素抗生素的化学酶法合成。
Biochemistry. 2007 Jul 17;46(28):8462-71. doi: 10.1021/bi700433v. Epub 2007 Jun 20.
7
Novel acyl phosphate mimics that target PlsY, an essential acyltransferase in gram-positive bacteria.靶向PlsY(革兰氏阳性菌中的一种必需酰基转移酶)的新型酰基磷酸模拟物。
ChemMedChem. 2008 Dec;3(12):1936-45. doi: 10.1002/cmdc.200800218.
8
Covalent CouN7 enzyme intermediate for acyl group shuttling in aminocoumarin biosynthesis.用于氨基香豆素生物合成中酰基穿梭的共价CouN7酶中间体。
Chem Biol. 2007 Jun;14(6):679-90. doi: 10.1016/j.chembiol.2007.05.007.
9
Insights into bacterial 6-methylsalicylic acid synthase and its engineering to orsellinic acid synthase for spirotetronate generation.对细菌6-甲基水杨酸合酶的见解及其改造为用于生成多杀霉素的苔色酸合酶的研究。
Chem Biol. 2010 May 28;17(5):495-503. doi: 10.1016/j.chembiol.2010.04.009.
10
Multiple complexes of long aliphatic N-acyltransferases lead to synthesis of 2,6-diacylated/2-acyl-substituted glycopeptide antibiotics, effectively killing vancomycin-resistant enterococcus.多种长链脂肪酰基转移酶复合物导致 2,6-二酰化/2-酰基取代糖肽抗生素的合成,有效地杀死耐万古霉素的肠球菌。
J Am Chem Soc. 2014 Aug 6;136(31):10989-95. doi: 10.1021/ja504125v. Epub 2014 Jul 25.

引用本文的文献

1
An NADH/NAD-favored aldo-keto reductase facilitates avilamycin A biosynthesis by primarily catalyzing oxidation of avilamycin C.一种 NADH/NAD 偏好型醛酮还原酶主要通过催化avilamycin C 的氧化来促进avilamycin A 的生物合成。
Appl Environ Microbiol. 2024 Apr 17;90(4):e0015024. doi: 10.1128/aem.00150-24. Epub 2024 Mar 29.

本文引用的文献

1
Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes.产色链霉菌wblA基因破坏突变体产生的新型泰乐菌素类似物的鉴定
Microb Cell Fact. 2015 Nov 2;14:173. doi: 10.1186/s12934-015-0359-5.
2
Identification and analysis of the paulomycin biosynthetic gene cluster and titer improvement of the paulomycins in Streptomyces paulus NRRL 8115.保罗霉素生物合成基因簇的鉴定与分析以及提高保罗链霉菌NRRL 8115中保罗霉素的产量
PLoS One. 2015 Mar 30;10(3):e0120542. doi: 10.1371/journal.pone.0120542. eCollection 2015.
3
Investigation of acyl migration in mono- and dicaffeoylquinic acids under aqueous basic, aqueous acidic, and dry roasting conditions.
单咖啡酰奎尼酸和二咖啡酰奎尼酸在碱性水溶液、酸性水溶液及干焙烤条件下的酰基迁移研究。
J Agric Food Chem. 2014 Sep 17;62(37):9160-70. doi: 10.1021/jf5017384. Epub 2014 Sep 8.
4
Structure of the O-polysaccharide of Pseudomonas mandelii CYar1 containing 3,6-dideoxy-4-C-[(S)-1-hydroxyethyl]-D-xylo-hexose (yersiniose A).假单胞菌曼德尔氏菌 CYar1 O-多糖的结构,其含有 3,6-二脱氧-4-C-[(S)-1-羟基乙基]-D-木糖(耶尔森糖 A)。
Carbohydr Res. 2013 Nov 15;381:138-41. doi: 10.1016/j.carres.2013.08.016. Epub 2013 Aug 25.
5
A one-step cloning method for the construction of somatic cell gene targeting vectors: application to production of human knockout cell lines.一步克隆法构建体细胞基因打靶载体:在生产人基因敲除细胞系中的应用。
BMC Biotechnol. 2012 Oct 9;12:71. doi: 10.1186/1472-6750-12-71.
6
Development of a fluorogenic probe with a transesterification switch for detection of histone deacetylase activity.开发一种具有转酯化开关的荧光探针,用于检测组蛋白去乙酰化酶活性。
J Am Chem Soc. 2012 Sep 5;134(35):14310-3. doi: 10.1021/ja306045j. Epub 2012 Aug 23.
7
Structure of the O-antigen of Budvicia aquatica 20186, a new bacterial polysaccharide that contains 3,6-dideoxy-4-C-[(S)-1-hydroxyethyl]-D-xylo-hexose (yersiniose A).水栖栖热菌 20186 型 O-抗原的结构,一种新型细菌多糖,含有 3,6-二脱氧-4-C-[(S)-1-羟基乙基]-D-木酮糖(耶尔森糖 A)。
Carbohydr Res. 2012 May 1;352:219-22. doi: 10.1016/j.carres.2012.02.017. Epub 2012 Feb 24.
8
Genetic analysis of the O-antigen gene clusters of Yersinia pseudotuberculosis O:6 and O:7.对小肠结肠炎耶尔森氏菌 O:6 和 O:7 的 O-抗原基因簇进行遗传分析。
Glycobiology. 2011 Sep;21(9):1140-6. doi: 10.1093/glycob/cwr010. Epub 2011 Feb 16.
9
Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogens.甘露肽霉素的生物合成途径,甘露肽霉素是一种对耐药革兰氏阳性病原体有效的脂糖肽类抗生素。
Antimicrob Agents Chemother. 2006 Jun;50(6):2167-77. doi: 10.1128/AAC.01545-05.
10
Genes involved in formation and attachment of a two-carbon chain as a component of eurekanate, a branched-chain sugar moiety of avilamycin A.与作为阿维拉霉素A的支链糖部分的优瑞卡酸的一个二碳链组成成分的形成和连接相关的基因。
Appl Environ Microbiol. 2005 Jan;71(1):400-6. doi: 10.1128/AEM.71.1.400-406.2005.